Semaglutide -New once-weekly option for Type 2 diabetes approved Dr. Kamal Kant Kohli Kohli5 Dec 2017 7:25 PM ISTEndocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) approved once-weekly semaglutide to...
Surgeons remove cancerous lymph nodes through hidden scar procedure Anjali Nimesh Nimesh6 Dec 2017 7:01 PM ISTA team of surgeons at Mount Sinai Beth Israel, led by Hyunsuk Suh, MD, Assistant Professor in the Department of Surgery at the Icahn School of...
Cystic Fibrosis Drug Shows Promise in Children as Young as 1 Year of Age Anjali Nimesh Nimesh10 Dec 2017 7:18 PM ISTAnn & Robert H. Lurie Children’s Hospital of Chicago is one of the study sites in the open-label Phase 3 study that showed safety and...
Metformin better than sulfonylureas as first-line therapy for patients with CKD Dr. Kamal Kant Kohli Kohli13 Dec 2017 7:30 PM ISTIn an observational study, it has been found that Metformin was associated with a lower risk of mortality than sulfonylureas both overall and in all...
FDA launches new tool for managing antibiotic use and improve patient care Anjali Nimesh Nimesh14 Dec 2017 7:00 PM ISTU.S. Food and Drug Administration is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care...
“Every Try Counts” FDA launches campaign to encourage smokers to quit smoking Anjali Nimesh Nimesh14 Dec 2017 7:02 PM ISTU.S. Food and Drug Administration announced an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit through...
FDA Safety alert for Product Marketed for Osteoarthritis Dr. Kamal Kant Kohli Kohli15 Dec 2017 7:02 PM ISTThe US Food and Drug Administration (FDA) has recommended that Limbrel, a capsule marketed to “manage the metabolic processes associated with...
Cell therapy leads to improvement in visual acuity in retinitis pigmentosa Dr. Kamal Kant Kohli Kohli16 Dec 2017 7:15 PM ISTCell therapy company jCyte has announced results from a phase 1/2a clinical trial for its investigational product, jCell, in retinitis pigmentosa...
Ozenoxacin Cream, 1%, a Novel Topical Antibiotic for Impetigo approved Anjali Nimesh Nimesh15 Dec 2017 7:28 PM ISTThe U.S. Food and Drug Administration (FDA) approved Ozenoxacin Cream, 1%, a new chemical entity for the treatment of impetigo in patients two months...
A New treatment option for Seborrheic Keratosis Dr. Kamal Kant Kohli Kohli17 Dec 2017 7:25 PM ISTThe US Food and Drug Administration (FDA) has approved a high-concentration hydrogen peroxide topical solution (Eskata, Aclaris Therapeutics) for the...
FDA approves premixed, low-volume colon-cleansing solution Dr. Kamal Kant Kohli Kohli18 Dec 2017 7:05 PM ISTThe Food and Drug Administration has approved a premixed sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution (Clenpiq) for...
FDA proposes risk-based enforcement approach to homeopathic drugs Anjali Nimesh Nimesh19 Dec 2017 7:05 PM ISTU.S. Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who...
